B. Kurland

发表

Misspecified maximum likelihood estimates and generalised linear mixed models

P. Heagerty, B. Kurland, 2001 .

Differential diagnosis of mammographically and clinically occult breast lesions on diffusion‐weighted MRI

Wendy B DeMartini, Brenda F Kurland, Savannah C Partridge, 2010, Journal of magnetic resonance imaging : JMRI.

Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease

Charles D. Smith, J. Morris, R. Petersen, 2009, Neurobiology of Aging.

ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial

D. Hayes, E. Mendez, B. Kurland, 2013, British Journal of Cancer.

Promise and pitfalls of quantitative imaging in oncology clinical trials.

L. Schwartz, F. Lieberman, J. Buatti, 2012, Magnetic resonance imaging.

Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients

Adrian V. Lee, P. Lucas, M. Nikiforova, 2015, Clinical Cancer Research.

The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective.

Paul Kinahan, P. Lambin, D. Mankoff, 2018, International journal of radiation oncology, biology, physics.

Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value.

Wendy B DeMartini, Brenda F Kurland, Savannah C Partridge, 2009, AJR. American journal of roentgenology.

Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.

Julie R. Gralow, David A. Mankoff, Robert B. Livingston, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Structural and Molecular Imaging in Cancer Therapy Clinical Trials

D. Mankoff, B. Kurland, 2012 .

Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics

Wendy B DeMartini, C. Lehman, S. Peacock, 2011, European Radiology.

Multicenter trials using 18F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: Effects of differential measurement error and bias on power calculations for unselected and enrichment designs

Paul Kinahan, D. Mankoff, H. Linden, 2013, Clinical trials.

Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF

Paul E Kinahan, Mark Muzi, David A Mankoff, 2007, Journal of Nuclear Medicine.

Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size

Paul Kinahan, D. Mankoff, H. Linden, 2015, The Journal of Nuclear Medicine.

PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake

D. Mankoff, H. Linden, R. Livingston, 2011, Clinical Cancer Research.

Effect of 18F-FDG Uptake Time on Lesion Detectability in PET Imaging of Early-Stage Breast Cancer

Paul E. Kinahan, Kristen A. Wangerin, Mark Muzi, 2015, Tomography.

Tumor-induced lymph node alterations detected by MRI lymphography using gadolinium nanoparticles

A. Ruddell, S. Partridge, B. Kurland, 2015, Scientific Reports.

Longitudinal Data with Follow-up Truncated by Death: Finding a Match Between Analysis Method and Research Aims

B. Kurland, P. Diehr, L. L. Johnson, 2007 .

Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients

D. Mankoff, H. Linden, R. Livingston, 2012, EJNMMI Research.

Abstract P4-01-02: The role of FLT PET early assessment of response to endocrine therapy for early stage breast cancer

D. Mankoff, H. Linden, J. Eary, 2013 .

DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer Presence

D. Gur, B. Kurland, J. Sumkin, 2017, Scientific Reports.

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium

M. Ladanyi, A. Iafrate, M. Kris, 2015, Cancer.

Heterogeneity in Metastatic Breast Cancer 18F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?

B. Kurland, S. Oesterreich, 2018, The Journal of Nuclear Medicine.

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Blood.

Internal Mammary Nodal Chain Drainage Is a Prognostic Indicator in Axillary Node-Positive Breast Cancer

D. Mankoff, B. Kurland, D. Byrd, 2007, Annals of Surgical Oncology.

Radiomic Analysis: Study Design, Statistical Analysis, and Other Bias Mitigation Strategies.

Amber L. Simpson, M. Jacobs, B. Kurland, 2022, Radiology.

Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips.

C. Lehman, S. Peacock, B. Kurland, 2010, Academic radiology.

Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.

D. Wood, B. Kurland, J. Bauman, 2008, The Annals of thoracic surgery.

Test–Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network

Darrin W. Byrd, Paul Kinahan, D. Mankoff, 2018, The Journal of Nuclear Medicine.

Diffusion-Weighted Breast Magnetic Resonance Imaging: A Semiautomated Voxel Selection Technique Improves Interreader Reproducibility of Apparent Diffusion Coefficient Measurements

Matthew L. Olson, Joshua O. Usoro, J. Scheel, 2016, Journal of computer assisted tomography.

18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer

D. Mankoff, H. Linden, J. Eary, 2020, The Journal of Nuclear Medicine.

Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by 18F-Fluoroestradiol PET

D. Mankoff, H. Linden, B. Kurland, 2011, The Journal of Nuclear Medicine.

QIN. Promise and pitfalls of quantitative imaging in oncology clinical trials

L. Schwartz, J. Buatti, J. Mountz, 2012 .

Considerations for using PET as a response measure in multicenter clinical trials

Paul Kinahan, D. Mankoff, B. Kurland, 2009 .

Clinical Trial Design and Development Work Group Within the Quantitative Imaging Network

D. Mankoff, L. Schwartz, J. Buatti, 2020, Tomography.

Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence

J. Herman, T. Burns, S. Dacic, 2017, The Journal of Biological Chemistry.

Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco‐Induced Lung Cancer

J. Siegfried, B. Kurland, B. Diergaarde, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma

A. Panigrahy, B. Kurland, R. Ceschin, 2015, American Journal of Neuroradiology.

18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study

Darrin W. Byrd, Paul Kinahan, D. Mankoff, 2021, Breast cancer research : BCR.

Accrual Patterns for Clinical Studies Involving Quantitative Imaging: Results of an NCI Quantitative Imaging Network (QIN) Survey

T. Yankeelov, J. Buatti, J. Mountz, 2016, Tomography.

FDG PET and FES PET Predict PFS on Endocrine Therapy—Response

D. Mankoff, H. Linden, B. Kurland, 2018, Clinical Cancer Research.

FDG PET and FES PET Predict PFS on Endocrine Therapy—Response

D. Mankoff, H. Linden, B. Kurland, 2017, Clinical Cancer Research.

Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.

M. Mrugala, B. Kurland, J. Gralow, 2019, Clinical breast cancer.

Multicenter clinical trials using 18 F-FDG PET to measure early response to oncologic therapy

Paul Kinahan, D. Mankoff, H. Linden, 2016 .

Pulmonary symptoms measured by the NIH Lung score predict overall survival, non-relapse mortality and patient-reported outcomes in chronic GVHD

W. Wood, B. Kurland, J. Pidala, 2014 .

Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

W. Wood, B. Kurland, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Circulating biomarkers in patients receiving neoadjuvant chemotherapy combined with sunitinib for locally advanced breast cancer.

R. Livingston, B. Kurland, A. Stopeck, 2013 .

A phase II study evaluating the safety and efficacy of sunitinib with weekly paclitaxel followed by doxorubicin and daily oral cyclophosphamide plus G-CSF as neoadjuvant chemotherapy (NC) for locally advanced (LABC) or inflammatory breast cancer (IBC).

H. Linden, R. Livingston, B. Kurland, 2013 .

Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403

C. Laymon, B. Kurland, L. Rigatti, 2019, Molecular Imaging and Biology.

Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer

B. Kurland, C. Anderson, D. Zeng, 2015, Molecular Imaging and Biology.

assessment Quantitative imaging biomarkers: A review of statistical methods for technical performance

Nicholas Petrick, Brian S. Garra, Adam J. Schwarz, 2014 .

Analysis of gastrointestinal and hepatic chronic grant-versus-host disease manifestations on major outcomes

B. Kurland, J. Pidala, Stephanie J. Lee, 2013 .

Do non-daily smokers compensate for reduced cigarette consumption when smoking very-low-nicotine-content cigarettes?

Sarah M. Scholl, S. Shiffman, B. Kurland, 2018, Psychopharmacology.

Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.

B. Kurland, K. Syrjala, J. Heiman, 2008, Blood.

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2011, Blood.

Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.

Brenda F Kurland, Chaitanya Divgi, Hannah M Linden, 2020, The oncologist.

Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment

Mithat Gönen, Paul L Carson, James T Voyvodic, 2015, Statistical methods in medical research.

Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer

D. Mankoff, H. Linden, R. Livingston, 2011, Clinical Cancer Research.

Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody

A. Panigrahy, B. Kurland, C. Anderson, 2019, Molecular Imaging and Biology.

Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody

A. Panigrahy, B. Kurland, C. Anderson, 2019, bioRxiv.

A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors

P. Nelson, R. Vessella, C. Higano, 2013, PloS one.

PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies

Ludmila V. Danilova, J. Herman, P. Wipf, 2020, Epigenetics.

Insulin receptor substrate-1 deficiency drives a proinflammatory phenotype in KRAS mutant lung adenocarcinoma

A. M. Houghton, M. White, B. Kurland, 2016, Proceedings of the National Academy of Sciences.

ATM protein is deficient in over 40% of lung adenocarcinomas

J. Siegfried, T. Conrads, S. Dacic, 2016, Oncotarget.

Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions

David O Wilson, Hui-Min Lin, Brenda F Kurland, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.

H. Linden, B. Kurland, J. Gralow, 2021, Clinical breast cancer.

Comparison of PD‐L1 immunohistochemistry assays and response to PD‐1/L1 inhibitors in advanced non‐small‐cell lung cancer in clinical practice

S. Dacic, B. Kurland, C. Herbst, 2018, Histopathology.

Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation–Associated Breast Cancer

H. Linden, P. Porter, E. Swisher, 2016, Clinical Cancer Research.

Assessment of Joint and Fascia Manifestations in Chronic Graft‐Versus‐Host Disease

J. Goldberg, B. Kurland, J. Pidala, 2014, Arthritis & rheumatology.

External beam radiation therapy and abiraterone in men with localized prostate cancer: safety and effect on tissue androgens.

K. Russell, B. Kurland, J. Liao, 2015, International journal of radiation oncology, biology, physics.

Combined Targeted Therapies for First‐line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab‐Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib

H. Linden, B. Kurland, J. Gralow, 2019, Clinical breast cancer.

Phase I: Veliparib with cisplatin (CP) and vinorelbine (VNR) in advanced triple-negative breast cancer (TNBC) and/or BRCA mutation-associated breast cancer.

H. Linden, P. Porter, E. Swisher, 2014 .

Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium

B. Kurland, J. Pidala, M. Flowers, 2013, Bone Marrow Transplantation.

Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium

B. Kurland, J. Pidala, Stephanie J. Lee, 2011, Haematologica.

Longitudinal Change in Positive Affect in Community‐Dwelling Older Persons

T. Gill, B. Kurland, E. Phelan, 2006, Journal of the American Geriatrics Society.

Serial 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)

D. Mankoff, H. Linden, R. Livingston, 2007, Breast Cancer Research and Treatment.

Nondaily Smokers’ Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical Trial

Sarah M. Scholl, S. Shiffman, B. Kurland, 2018, JAMA psychiatry.

Acquired Resistance to the Hsp90 Inhibitor, Ganetespib, in KRAS-Mutant NSCLC Is Mediated via Reactivation of the ERK–p90RSK–mTOR Signaling Network

T. Burns, B. Kurland, S. Chatterjee, 2017, Molecular Cancer Therapeutics.

Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study

B. Kurland, J. Pidala, M. Arora, 2013, Leukemia.

Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.

B. Kurland, J. Pidala, Stephanie J. Lee, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Summary: Appropriate Use Criteria for Estrogen Receptor–Targeted PET Imaging with 16α-18F-Fluoro-17β-Fluoroestradiol

D. Mankoff, H. Linden, E. de Vries, 2023, The Journal of Nuclear Medicine.

Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer

D. Mankoff, H. Linden, R. Livingston, 2010, Clinical Cancer Research.

Use of serial 18F-Fluorothymidine (FLT) PET and Ki-67 to predict response to aromatase inhibitors (AI) in women with ER+ breast cancer.

D. Mankoff, H. Linden, J. Eary, 2016 .

Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial.

D. Hayes, N. Futran, E. Mendez, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of measurement scales in ocular graft-versus-host disease.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Ophthalmology.

Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer

H. Linden, B. Kurland, J. Gralow, 2017, Clinical breast cancer.

Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.

S. Dikmen, B. Kurland, S. Langer, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

B. Kurland, B. Egleston, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High Epidermal Growth Factor Receptor Expression in Metastatic Colorectal Cancer Lymph Nodes May Be More Prognostic of Poor Survival Than in Primary Tumor

B. Kurland, E. Lin, Wen Li, 2009, American journal of clinical oncology.

Combined VLA-4–Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma

C. Laymon, B. Kurland, C. Anderson, 2018, The Journal of Nuclear Medicine.

RACE/ETHNIC DIFFERENCES IN AD SURVIVAL IN US ALZHEIMER'S DISEASE CENTERS

A. Stewart, E. Perez-stable, K. Mehta, 2008, Neurology.

Dinner talk: Cultural patterns of sociability and socialization in family discourse . Shoshana Blum-Kulka. Mahwah, NJ: Erlbaum, 1997. PP. 306.

B. Kurland, 1998, Applied Psycholinguistics.

Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.

Wendy B DeMartini, Brenda F Kurland, Savannah C Partridge, 2010, AJR. American journal of roentgenology.

Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast‐enhanced kinetics

Wendy B DeMartini, C. Lehman, S. Partridge, 2011, Magnetic resonance in medicine.

Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer

R. Nishikawa, D. Gur, B. Kurland, 2016, Breast Cancer Research.

A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)

D. Mankoff, H. Linden, J. Eary, 2014, Molecular Imaging and Biology.

The burden and patterns of disability in activities of daily living among community-living older persons.

Thomas M Gill, T. Gill, B. Kurland, 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

Directly parameterized regression conditioning on being alive: analysis of longitudinal data truncated by deaths.

Patrick J Heagerty, Brenda F Kurland, P. Heagerty, 2005, Biostatistics.

Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium.

B. Kurland, B. Goff, L. Holmberg, 2008, Gynecologic oncology.

Longitudinal Data with Follow-up Truncated by Death: Match the Analysis Method to Research Aims.

Brenda F Kurland, Brian L Egleston, B. Kurland, 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.

A 3-dimensional analysis of molar movement during headgear treatment.

Brenda F Kurland, Joseph Ghafari, D. Ramsay, 2002, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

SHELL: Oral Language and Early Literacy Skills in Kindergarten and First-Grade Children

Catherine E. Snow, Patton O. Tabors, Brenda F. Kurland, 1995 .

Measurement of Oral Chronic Graft-Versus-Host Disease

B. Kurland, J. Pidala, M. Flowers, 2012 .

B. Kurland, M. Flowers, M. Arora, 2012 .

Quantitative assessment of dynamic PET imaging data in cancer imaging.

Paul E Kinahan, Finbarr O'Sullivan, Larry A Pierce, 2012, Magnetic resonance imaging.

BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.

Wendy B DeMartini, C. Lehman, S. Peacock, 2009, AJR. American journal of roentgenology.

Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions.

Wendy B DeMartini, C. Lehman, S. Peacock, 2009, Academic radiology.

Association between serial dynamic contrast‐enhanced MRI and dynamic 18F‐FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer